Letter in response to Salari M,et al. Epidemiology and clinical features of Huntington's disease in MENASA region: A systematic review and meta-analysis
Restricted accessLetterFirst published online February, 2026
Letter in response to Salari M,et al. Epidemiology and clinical features of Huntington's disease in MENASA region: A systematic review and meta-analysis
SalariMRezaeiKHojjatti PourF, et al.Epidemiology and clinical features of Huntington’s disease in MENASA region: A systematic review and meta-analysis. J Huntington Dis2025; 14: 319–330.
2.
ThompsonAQuarrellOStrongM. Variation in the reported prevalence of Huntington’s disease: a systematic review and guide to interpretation. J Neurology2025; 272: 534.
3.
DeeksJJHigginsJPAltmanDG, et al. Chapter 10: Analysing data and undertaking meta-analyses. Cochrane Handbook. https://www.cochrane.org/authors/handbooks-andmanuals/handbook/current/chapter-10 (2024, accessed 10 September 2025).
4.
KandilMRTohamySAFattahMA, et al.Prevalence of chorea, dystonia and athetosis in assiut, Egypt: a clinical and epidemiological study. Neuroepidemiology1994; 13: 202–210.
5.
ShiwachRSLindenbaumRH. Prevalence of Huntington’s disease among UK immigrants from the Indian subcontinent. Br J Psychiatry1990; 157: 598–599.
6.
RibalovRYaariAChodickG, et al.PND67 The real-world epidemiology and treatment patterns of Huntington’s disease in Israel. Value Health2020; 23: S635.
7.
Gavrielov-YusimNBarerYMartinecM, et al.Huntington’s disease in Israel: a population-based study using 20 years of routinely-collected healthcare data. J Huntingtons Dis2021; 10: 469–477.
8.
SquitieriFMaffiSAl HarasiS, et al.Incidence and prevalence of Huntington disease (HD) in the sultanate of Oman: the first Middle East post-HTT service-based study. J Neurol Neurosurg Psychiatry2020; 91: 1359–1360.
